Összesen 2 találat.


001-es BibID:BIBFORM106630
Első szerző:Ghansah, Harriet (PhD)
Cím:Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C / Harriet Ghansah, Ildikó Beke Debreceni, László Váróczy, László Rejtő, Linda Lóczi, Zsuzsa Bagoly, János Kappelmayer
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Thrombosis Research. - 223 (2023), p. 44-52. -
További szerzők:Bekéné Debreceni Ildikó Váróczy László (1974-) (belgyógyász, haematológus) Rejtő László (1963-) (belgyógyász, haematológus) Lóczi Linda Bagoly Zsuzsa (1978-) (orvos) Kappelmayer János (1960-) (laboratóriumi szakorvos)
Pályázati támogatás:GINOP-2.3.2-15-2016-00043
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat


001-es BibID:BIBFORM082985
035-os BibID:(PMID)31808421
Első szerző:Lóczi Linda
Cím:Antiphospholipid syndrome and the risk of myocardial infarction : current evidence and uncertainties / Linda Lóczi, János Kappelmayer, Tünde Tarr, Zsuzsa Bagoly
Megjegyzések:Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations that may prevail in the form of venous or arterial thrombosis or lead to pregnancy complications in the presence of persisting antiphospholipid antibodies (aPL). Unlike in the case of congenital thrombophilias, in which venous thromboses are more likely to occur as compared with arterial events, aPL may cause thrombosis in both types of vascular systems. Arterial thrombosis in APS is fairly common and often involve coronary or cerebral arteries leading to myocardial infarction (MI) or stroke. In this review, we summarize the complex pathomechanisms leading to aPL?associated thrombosis and list challenges during the laboratory detection of these antibodies. Specific features of MI in patients with APS are summarized based on a comprehensive literature search of available case reports. Preventive and treatment strategies are discussed based on the current recommendations and most recent evidence. We conclude that the risk of MI in patients with APS is considerable and MI may be the first manifestation of the disease. MI in APS shows specific clinical features including relatively young age at presentation, no sex dominance, often normal coronaries without the sign of atherosclerosis, high risk of recurrent thrombotic events. Treatment of acute MI in patients with APS is often challenging and adverse events, including stent thrombosis, are more frequent as compared with patients without APS. Preventive strategies in APS should be personalized and include strict management of additional cardiovascular risk factors and long?term anticoagulation with vitamin K antagonists. Current evidence does not support the use of direct oral anticoagulants in the management of patients with APS with arterial thrombosis due to the high risk of recurrent events.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Kardiologia Polska. - 78 : 1 (2020), p. 6-14. -
További szerzők:Kappelmayer János (1960-) (laboratóriumi szakorvos) Tarr Tünde (1976-) (belgyógyász, allergológus és klinikai immunológus) Bagoly Zsuzsa (1978-) (orvos)
Pályázati támogatás:FK128582
Internet cím:Szerző által megadott URL
Intézményi repozitóriumban (DEA) tárolt változat
Rekordok letöltése1